Populations who should not use BPC-157: Pregnant or breastfeeding individuals (no safety data), anyone with a history of cancer (theoretical concern given pro-angiogenic mechanisms), individuals taking anticoagulants (some animal data suggest effects on platelet aggregation pathways), and anyone without access to sterile technique for injection preparation
The reductions in PCSK1 levels, as a result of CerS2 ablation, are due to impaired processing of the pro-PCSK1 protein which normally occurs as it transits from the endoplasmic reticulum (ER) to the Golgi
Akkermansia muciniphila is often reported to increase, and in certain studies this shift has been linked to improved metabolic profiles and enhanced treatment response [118, 119, 123, 125, 126]
Tirzepatide affects multiple systems simultaneously: appetite regulation, gut motility, insulin secretion, glucagon suppression
This helps your digestive system anticipate and process food more effectively
Recent research has focused on its ability to support liver function in those with steatosis, the infiltration of fat into the liver leading to liver dysfunction